KRM Ayurveda Ltd IPO: KRM Ayurveda Limited, a prominent player in the AYUSH healthcare sector, is launching its Initial Public Offering (IPO) on January 19, 2026. Known for its specialized Ayurvedic kidney care and a growing network of multi-specialty hospitals, the company aims to raise approximately ₹77.49 Crores to expand its telemedicine and digital health infrastructure.
KRM Ayurveda IPO Overview
The IPO is an entirely fresh issue, meaning the capital raised will go directly into the company’s growth and expansion.
| Feature | Details |
| IPO Open Date | Monday, January 19, 2026 |
| IPO Close Date | Wednesday, January 21, 2026 |
| Price Band | ₹128 to ₹135 per share |
| Lot Size | 1,000 Shares |
| Total Issue Size | ₹77.49 Crores (57.40 Lakh Shares) |
| Listing At | NSE SME |
| Face Value | ₹10 per share |
KRM Ayurveda IPO Important Dates
Tracking the timeline is crucial for successful bidding and checking allotment results.
- IPO Open Date: Jan 19, 2026
- IPO Close Date: Jan 21, 2026
- Basis of Allotment: Thursday, Jan 22, 2026
- Initiation of Refunds: Friday, Jan 23, 2026
- Credit of Shares to Demat: Friday, Jan 23, 2026
- Listing Date: Tuesday, Jan 27, 2026
KRM Ayurveda IPO GMP Today (Grey Market Premium)
As of January 18, 2026, the KRM Ayurveda IPO is seeing positive momentum in the grey market.
- Current GMP: ~₹15 – ₹20
- Estimated Listing Price: ₹150 – ₹155
- Potential Listing Gain: ~11% to 15%
Note: GMP is based on market rumors and unofficial trading. Always consult a financial advisor before investing.
Lot Size & Investment for Retail & HNI
Retail investors can apply for a minimum and maximum of 2 lots (2,000 shares) in this SME issue.
| Investor Category | Lots | Shares | Amount |
| Retail (Min/Max) | 2 | 2,000 | ₹2,70,000 |
| S-HNI (Min) | 3 | 3,000 | ₹4,05,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,80,000 |
Company Financials: Performance at a Glance
KRM Ayurveda has shown a significant “U-turn” in profitability in the last fiscal year.
| Financial Year | Revenue (₹ Cr) | Net Profit (PAT) (₹ Cr) | Net Worth (₹ Cr) |
| FY 2023 | 89.38 | 7.60 | 8.37 |
| FY 2024 | 67.57 | 3.41 | 11.78 |
| FY 2025 | 76.95 | 12.10 | 23.88 |
Key Metric: The company reported a high PAT Margin of ~15.7% for FY25, a massive improvement from previous years, indicating better cost management and service demand.
IPO Review: Should You Apply?
The Positives (Pros):
- Niche Expertise: Strong brand recall in specialized kidney care and chronic lifestyle diseases.
- Diversified Model: Combines physical hospitals (6) and clinics (5) with a global telemedicine reach.
- In-house Manufacturing: Operates a GMP-certified unit for 300+ Ayurvedic products.
The Risks (Cons):
- Geographic Concentration: Over 68% of revenue comes from Delhi and Haryana.
- High Attrition: The company has faced high employee turnover rates in the past.
- Leased Assets: Most operational facilities are on leased premises.
Verdict: The IPO is valued at a P/E of ~23.9x (post-issue). Compared to peers like Jeena Sikho (P/E 58x), it appears competitively priced. Aggressive investors looking for an “AYUSH theme” play may find this attractive for listing gains.
How to Check KRM Ayurveda Ltd IPO Allotment Status
Once the allotment is finalized on January 22, 2026, follow these steps:
- Visit the Skyline Financial Services Pvt Ltd (Registrar) website.
- Click on the “IPO Allotment Status“
- Select “KRM Ayurveda Limited” from the company list.
- Enter your PAN Card Number or Application Number.
- Click Submit to see your status.
Leave a Reply